| Name | Title | Contact Details |
|---|
The Washington Home is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. The Washington Home is based in Hagerstown, MD. You can find more information on The Washington Home at www.thewashingtonhome.org
Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company`s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health`s wearable therapy is essential tremor, a disease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
Global Clinical Trials is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Persante Health Care is a national provider of sleep and balance center management services to hospitals, physician practices and patients. Persante`s expertise in sleep and balance related disorders dates back almost 20 years under the names of Sleep Care Centers, Sleep Tech, Mid-Atlantic School of Sleep Medicine and Blackwood Medical. The merging of these four unique industry leaders revolutionized the out-sourced delivery model of sleep and balance diagnosis and therapeutic treatment. This comprehensive approach to serving our client`s patients in a high quality manner has earned recognition and accreditation from The American Academy of Sleep Medicine and The National Sleep Foundation.
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.